أرسل هذا في رسالة قصيرة: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

  _____     _____      _____    ______    _____   
 |__  //   |  ___||   / ___//  /_   _//  /  ___|| 
   / //    | ||__     \___ \\   -| ||-  | // __   
  / //__   | ||__     /    //   _| ||_  | \\_\ || 
 /_____||  |_____||  /____//   /_____//  \____//  
 `-----`   `-----`  `-----`    `-----`    `---`